Megan Molteni

NIH announced it will no longer allow subawards to foreign institutions, as part of a national security-minded overhaul to how it manages research funding

A NIH policy change on funding of foreign scientists is far more sweeping than described in a Thursday announcement

DOGE lists just over 400 NIH contracts it says have been cancelled under its directive to reduce contract spending by 35%

A federal appeals court said the patent office made legal errors in awarding foundational patents for CRISPR-Cas9 to the Broad Institute

Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on germline gene editing

Researchers have taken preliminary steps toward treating spinal muscular atrophy in the womb

Proposed rule could make NIH institute directors more accountable to the president

Nation's leading advisory body on issues of science and technology is "preparing for a fairly radical downsizing."

Committee calls for charter on technologies like CRISPR that protects human dignity

Renewals of existing multi-year grants have been especially hard hit by slowdown